From: Overexpression of MACC1 and Its significance in human Breast Cancer Progression
Characteristics | Cohort 1 | Cohort 2 | ||||
---|---|---|---|---|---|---|
 | MACC1 expression | MACC1 expression | ||||
 | Low | High | P-value | Low | High | P-value |
Age | Â | Â | Â | Â | Â | Â |
 ≤45 | 44 | 51 | 0.647 | 29 | 49 | 0.504 |
 >45 | 65 | 85 |  | 45 | 62 |  |
Menopausal status | Â | Â | Â | Â | Â | Â |
 Premenopausal | 56 | 60 | 0.799 |  |  |  |
 Postmenopausal | 51 | 51 |  |  |  |  |
Clinical stage | Â | Â | Â | Â | Â | Â |
 I | 43 | 38 | 0.001 | 19 | 2 | <0.001 |
 II | 45 | 46 |  | 37 | 43 |  |
 III | 15 | 25 |  | 14 | 45 |  |
 IV | 5 | 28 |  | 4 | 21 |  |
T classification | Â | Â | Â | Â | Â | Â |
 T1 | 61 | 49 | 0.019 | 23 | 13 | <0.001 |
 T2 | 39 | 68 |  | 39 | 53 |  |
 T3 | 6 | 12 |  | 11 | 30 |  |
 T4 | 3 | 7 |  | 1 | 15 |  |
N classification | Â | Â | Â | Â | Â | Â |
 N0 | 67 | 68 | 0.050 | 44 | 26 | <0.001 |
 N1 | 25 | 26 |  | 24 | 54 |  |
 N2 | 12 | 29 |  | 4 | 26 |  |
 N3 | 5 | 13 |  | 2 | 5 |  |
Distant metastasis | Â | Â | Â | Â | Â | Â |
 Yes | 104 | 108 | <0.001 | 0 | 8 | 0.022 |
 No | 5 | 28 |  | 74 | 103 |  |
Estrogen receptor | Â | Â | Â | Â | Â | Â |
 Positive | 79 | 95 | 0.653 | 36 | 65 | 0.185 |
 Negative | 30 | 41 |  | 38 | 46 |  |
Progesterone receptor | Â | Â | Â | Â | Â | Â |
 Positive | 63 | 83 | 0.990 | 43 | 67 | 0.760 |
 Negative | 32 | 42 |  | 31 | 44 |  |
Her2 | Â | Â | Â | Â | Â | Â |
 Positive | 21 | 22 | 0.862 | 8 | 13 | 0.480 |
 Negative | 71 | 79 |  | 36 | 41 |  |
Endocrine therapy | Â | Â | Â | Â | Â | Â |
 tamoxifen | 62 | 60 | 0.614 |  |  |  |
 No treatment | 45 | 50 |  |  |  |  |